Esophageal squamous cell carcinoma cells modulate chemokine expression and hyaluronan synthesis in fibroblasts

Journal of Biological Chemistry

Volumn 291, Issue 8, 2016, Pages 4091-4106

  Kretschmer, Inga ^a   Freudenberger, Till ^a   Twarock, Sören ^a   Yamaguchi, Yu ^b   Grandoch, Maria ^a   Fischer, Jens W ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CYTOLOGY; ENZYME ACTIVITY; FIBROBLASTS; HYALURONIC ACID; NUCLEIC ACIDS; PROTEINS; RNA; ROOM AND PILLAR MINING; TUMORS;

CHEMOKINE EXPRESSION; DOWNSTREAM TARGET; EPITHELIAL-MESENCHYMAL TRANSITION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; EXTRACELLULAR MATRIX COMPONENTS; HYALURONAN SYNTHESIS; IMMUNE RESPONSE; SMOOTH MUSCLE ACTINS;

CELLS;

ALPHA SMOOTH MUSCLE ACTIN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; COMPLEMENTARY RNA; EOTAXIN; HYALURONIC ACID; HYMECROMONE; RANTES; WNT PROTEIN; CCL11 PROTEIN, HUMAN; CCL5 PROTEIN, HUMAN; GLUCURONOSYLTRANSFERASE; HAS2 PROTEIN, HUMAN; LEF1 PROTEIN, HUMAN; LYMPHOID ENHANCER FACTOR 1; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE SYNTHESIS; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE; GENE EXPRESSION; HAS2 GENE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; SQUAMOUS CELL CARCINOMA CELL LINE; UPREGULATION; ANIMAL; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; ESOPHAGUS TUMOR; FIBROBLAST; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; WNT SIGNALING PATHWAY;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CHEMOKINE CCL11; CHEMOKINE CCL5; COCULTURE TECHNIQUES; ESOPHAGEAL NEOPLASMS; FIBROBLASTS; GLUCURONOSYLTRANSFERASE; HUMANS; HYALURONIC ACID; LYMPHOID ENHANCER-BINDING FACTOR 1; MICE; MICE, NUDE; NEOPLASM PROTEINS; WNT SIGNALING PATHWAY;

EID: 84964499540     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.708909     Document Type: Article

References (72)

1. Servais, C., and Erez, N. (2013) From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation. J. Pathol 229, 198-207.
2. Öhlund, D., Elyada, E., and Tuveson, D. (2014) Fibroblast heterogeneity in the cancer wound. J. Exp. Med. 211, 1503-1523.
3. Cirri, P., and Chiarugi, P. (2011) Cancer associated fibroblasts: The dark side of the coin. Am. J. Cancer Res. 1, 482-497.
4. Augsten, M. (2014) Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment. Front. Oncol. 4, 62.
5. Harper, J., and Sainson, R. C. (2014) Regulation of the anti-tumour immune response by cancer-associated fibroblasts. Semin. Cancer Biol. 25, 69-77.
6. Auvinen, P., Tammi, R., Parkkinen, J., Tammi, M., Agren, U., Johansson, R., Hirvikoski, P., Eskelinen, M., and Kosma, V. M. (2000) Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am. J. Pathol 156, 529-536.
7. Pirinen, R., Tammi, R., Tammi, M., Hirvikoski, P., Parkkinen, J. J., Johansson, R., Böhm, J., Hollmén, S., and Kosma, V. M. (2001) Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma. Int. J. Cancer 95, 12-17.
8. Twarock, S., Freudenberger, T., Poscher, E., Dai, G., Jannasch, K., Dullin, C., Alves, F., Prenzel, K., Knoefel, W. T., Stoecklein, N. H., Savani, R. C., Homey, B., and Fischer, J. W. (2011) Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis. Mol. Cancer 10, 30.
9. Golshani, R., Lopez, L., Estrella, V., Kramer, M., Iida, N., and Lokeshwar, V. B. (2008) Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44. Cancer Res. 68, 483-491.
10. Udabage, L., Brownlee, G. R., Waltham, M., Blick, T., Walker, E. C., Heldin, P., Nilsson, S. K., Thompson, E. W., and Brown, T. J. (2005) Antisensemediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer. Cancer Res. 65, 6139-6150.
11. Teng, B. P., Heffler, M. D., Lai, E. C., Zhao, Y. L., LeVea, C. M., Golubovskaya, V. M., and Bullarddunn, K. M. (2011) Inhibition of hyaluronan synthase- 3 decreases subcutaneous colon cancer growth by increasing apoptosis. Anticancer Agents Med. Chem. 11, 620-628.
12. Tian, X., Azpurua, J., Hine, C., Vaidya, A., Myakishev-Rempel, M., Ablaeva, J., Mao, Z., Nevo, E., Gorbunova, V., and Seluanov, A. (2013) Highmolecular- mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature 499, 346-349.
13. Itano, N., Sawai, T., Atsumi, F., Miyaishi, O., Taniguchi, S., Kannagi, R., Hamaguchi, M., and Kimata, K. (2004) Selective expression and functional characteristics of three mammalian hyaluronan synthases in oncogenic malignant transformation. J. Biol. Chem. 279, 18679-18687.
14. Li, Y., Li, L., Brown, T. J., and Heldin, P. (2007) Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells. Int. J. Cancer 120, 2557-2567.
15. Liu, N., Gao, F., Han, Z., Xu, X., Underhill, C. B., and Zhang, L. (2001) Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells. Cancer Res. 61, 5207-5214.
16. Koyama, H., Hibi, T., Isogai, Z., Yoneda, M., Fujimori, M., Amano, J., Kawakubo, M., Kannagi, R., Kimata, K., Taniguchi, S., and Itano, N. (2007) Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. Am. J. Pathol 170, 1086-1099.
17. Simpson, M. A., Wilson, C. M., and McCarthy, J. B. (2002) Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice. Am. J. Pathol 161, 849-857.
18. Zoltan-Jones, A., Huang, L., Ghatak, S., and Toole, B. P. (2003) Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells. J. Biol. Chem. 278, 45801-45810.
19. Vicent, S., Sayles, L. C., Vaka, D., Khatri, P., Gevaert, O., Chen, R., Zheng, Y., Gillespie, A. K., Clarke, N., Xu, Y., Shrager, J., Hoang, C. D., Plevritis, S., Butte, A. J., and Sweet-Cordero, E. A. (2012) Cross-species functional analysis of cancer-associated fibroblasts identifies a critical role for CLCF1 and IL-6 in non-small cell lung cancer in vivo. Cancer Res. 72, 5744-5756.
20. Rajaram, M., Li, J., Egeblad, M., and Powers, R. S. (2013) System-wide analysis reveals a complex network of tumor-fibroblast interactions involved in tumorigenicity. PLoS Genet. 9, e1003789.
21. Mitra, A. K., Zillhardt, M., Hua, Y., Tiwari, P., Murmann, A. E., Peter, M. E., and Lengyel, E. (2012) Micro RNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. Cancer Discov. 2, 1100-1108.
22. Sakko, A. J., Ricciardelli, C., Mayne, K., Tilley, W. D., Lebaron, R. G., and Horsfall, D. J. (2001) Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor 1. Cancer Res. 61, 926-930.
23. Pasonen-Seppänen, S., Takabe, P., Edward, M., Rauhala, L., Rilla, K., Tammi, M., and Tammi, R. (2012) Melanoma cell-derived factors stimulate hyaluronan synthesis in dermal fibroblasts by upregulating HAS2 through PDGFR-PI3K-AKT and p38 signaling. Histochem. Cell Biol. 138, 895-911.
24. Willenberg, A., Saalbach, A., Simon, J. C., and Anderegg, U. (2012) Melanoma cells control HA synthesis in peritumoral fibroblasts via PDGF-AA and PDGF-CC: impact on melanoma cell proliferation. J. Invest. Dermatol. 132, 385-393.
25. Matsumoto, K., Li, Y., Jakuba, C., Sugiyama, Y., Sayo, T., Okuno, M., Dealy, C. N., Toole, B. P., Takeda, J., Yamaguchi, Y., and Kosher, R. A. (2009) Conditional inactivation of Has2 reveals a crucial role for hyaluronan in skeletal growth, patterning, chondrocyte maturation and joint formation in the developing limb. Development 136, 2825-2835.
26. Seibler, J., Zevnik, B., Küter-Luks, B., Andreas, S., Kern, H., Hennek, T., Rode, A., Heimann, C., Faust, N., Kauselmann, G., Schoor, M., Jaenisch, R., Rajewsky, K., Kühn, R., and Schwenk, F. (2003) Rapid generation of inducible mouse mutants. Nucleic Acids Res. 31, e12.
27. Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., Tinevez, J. Y., White, D. J., Hartenstein, V., Eliceiri, K., Tomancak, P., and Cardona, A. (2012) Fiji: An open-source platform for biological-image analysis. Nat. Methods 9, 676-682.
28. Untergasser, A., Cutcutache, I., Koressaar, T., Ye, J., Faircloth, B. C., Remm, M., and Rozen, S. G. (2012) Primer3: new capabilities and interfaces. Nucleic Acids Res. 40, e115.
29. Ye, J., Coulouris, G., Zaretskaya, I., Cutcutache, I., Rozen, S., and Madden, T. L. (2012) Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 13, 134.
30. Flicek, P., Amode, M. R., Barrell, D., Beal, K., Billis, K., Brent, S., Carvalho- Silva, D., Clapham, P., Coates, G., Fitzgerald, S., Gil, L., Girón, C. G., Gordon, L., Hourlier, T., Hunt, S., Johnson, N., Juettemann, T., Kähäri, A. K., Keenan, S., Kulesha, E., Martin, F. J., Maurel, T., McLaren, W. M., Murphy, D. N., Nag, R., Overduin, B., Pignatelli, M., Pritchard, B., Pritchard, E., Riat, H. S., Ruffier, M., Sheppard, D., Taylor, K., Thormann, A., Trevanion, S. J., Vullo, A., Wilder, S. P., Wilson, M., Zadissa, A., Aken, B. L., Birney, E., Cunningham, F., Harrow, J., Herrero, J., Hubbard, T. J., Kinsella, R., Muffato, M., Parker, A., Spudich, G., Yates, A., Zerbino, D. R., and Searle, S. M. (2014) Ensembl 2014. Nucleic Acids Res. 42, D749-D755.
31. Cartharius, K., Frech, K., Grote, K., Klocke, B., Haltmeier, M., Klingenhoff, A., Frisch, M., Bayerlein, M., and Werner, T. (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21, 2933-2942.
32. Jamieson, C., Sharma, M., and Henderson, B. R. (2012) Wnt signaling from membrane to nucleus: catenin caught in a loop. Int. J. Biochem. Cell Biol. 44, 847-850.
33. Vigetti, D., Deleonibus, S., Moretto, P., Bowen, T., Fischer, J. W., Grandoch, M., Oberhuber, A., Love, D. C., Hanover, J. A., Cinquetti, R., Karousou, E., Viola, M., D'Angelo, M. L., Hascall, V. C., De Luca, G., and Passi, A. (2014) Natural antisense transcript for hyaluronan synthase 2 (HAS2-AS1) induces transcription of HAS2 via proteinO-GlcNAcylation. J. Biol. Chem. 289, 28816-28826.
34. Michael, D. R., Phillips, A. O., Krupa, A., Martin, J., Redman, J. E., Altaher, A., Neville, R. D., Webber, J., Kim, M. Y., and Bowen, T. (2011) The human hyaluronan synthase 2 (HAS2) gene and its natural antisense RNA exhibit coordinated expression in the renal proximal tubular epithelial cell. J. Biol. Chem. 286, 19523-19532.
35. Maeda-Sano, K., Gotoh, M., Morohoshi, T., Someya, T., Murofushi, H., and Murakami-Murofushi, K. (2014) Cyclic phosphatidic acid and lysophosphatidic acid induce hyaluronic acid synthesis via CREB transcription factor regulation in human skin fibroblasts. Biochim. Biophys. Acta 1841, 1256-1263.
36. Röck, K., Grandoch, M., Majora, M., Krutmann, J., and Fischer, J. W. (2011) Collagen fragments inhibit hyaluronan synthesis in skin fibroblasts in response to ultraviolet B (UVB): new insights into mechanisms of matrix remodeling. J. Biol. Chem. 286, 18268-18276.
37. Marieb, E. A., Zoltan-Jones, A., Li, R., Misra, S., Ghatak, S., Cao, J., Zucker, S., and Toole, B. P. (2004) Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production. Cancer Res. 64, 1229-1232.
38. Xu, J., Lu, Y., Qiu, S., Chen, Z. N., and Fan, Z. (2013) A novel role of EMMPRIN/CD147 in transformation of quiescent fibroblasts to cancerassociated fibroblasts by breast cancer cells. Cancer Lett. 335, 380-386.
39. Kobayashi, N., Miyoshi, S., Mikami, T., Koyama, H., Kitazawa, M., Takeoka, M., Sano, K., Amano, J., Isogai, Z., Niida, S., Oguri, K., Okayama, M., McDonald, J. A., Kimata, K., Taniguchi, S., and Itano, N. (2010) Hyaluronan deficiency in tumor stroma impairs macrophage trafficking and tumor neovascularization. Cancer Res. 70, 7073-7083.
40. Alaniz, L., Rizzo, M., Malvicini, M., Jaunarena, J., Avella, D., Atorrasagasti, C., Aquino, J. B., Garcia, M., Matar, P., Silva, M., and Mazzolini, G. (2009) Low molecular weight hyaluronan inhibits colorectal carcinoma growth by decreasing tumor cell proliferation and stimulating immune response. Cancer Lett. 278, 9-16.
41. Aldinucci, D., and Colombatti, A. (2014) The inflammatory chemokine CCL5 and cancer progression. Mediators Inflamm. 2014, 292376.
42. Soon, P. S., Kim, E., Pon, C. K., Gill, A. J., Moore, K., Spillane, A. J., Benn, D. E., and Baxter, R. C. (2013) Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells. Endocr. Relat. Cancer 20, 1-12.
43. Kim, S. H., Choe, C., Shin, Y. S., Jeon, M. J., Choi, S. J., Lee, J., Bae, G. Y., Cha, H. J., and Kim, J. (2013) Human lung cancer-associated fibroblasts enhance motility of non-small cell lung cancer cells in co-culture. Anticancer Res. 33, 2001-2009.
44. Zhang, C., Fu, L., Fu, J., Hu, L., Yang, H., Rong, T. H., Li, Y., Liu, H., Fu, S. B., Zeng, Y. X., and Guan, X. Y. (2009) Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma. Clin. Cancer Res. 15, 4017-4027.
45. Wan, X., Liu, J., Lu, J. F., Tzelepi, V., Yang, J., Starbuck, M. W., Diao, L., Wang, J., Efstathiou, E., Vazquez, E. S., Troncoso, P., Maity, S. N., and Navone, N. M. (2012) Activation of catenin signaling in androgen receptor-negative prostate cancer cells. Clin. Cancer Res. 18, 726 -736.
46. Simpson, R. M., Wells, A., Thomas, D., Stephens, P., Steadman, R., and Phillips, A. (2010) Aging fibroblasts resist phenotypic maturation because of impaired hyaluronan-dependent CD44/epidermal growth factor receptor signaling. Am. J. Pathol. 176, 1215-1228.
47. Webber, J., Jenkins, R. H., Meran, S., Phillips, A., and Steadman, R. (2009) Modulation of TGF1-dependent myofibroblast differentiation by hyaluronan. Am. J. Pathol. 175, 148-160.
48. Noma, K., Smalley, K. S., Lioni, M., Naomoto, Y., Tanaka, N., El-Deiry, W., King, A. J., Nakagawa, H., and Herlyn, M. (2008) The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis. Gastroenterology 134, 1981-1993.
49. Mi, Z., Bhattacharya, S. D., Kim, V. M., Guo, H., Talbot, L. J., and Kuo, P. C. (2011) Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis. Carcinogenesis 32, 477-487.
50. Hodge-Dufour, J., Noble, P. W., Horton, M. R., Bao, C., Wysoka, M., Burdick, M. D., Strieter, R. M., Trinchieri, G., and Puré, E. (1997) Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. J. Immunol. 159, 2492-2500.
51. Suga, H., Sugaya, M., Fujita, H., Asano, Y., Tada, Y., Kadono, T., and Sato, S. (2014) TLR4, rather than TLR2, regulates wound healing through TGFbeta and CCL5 expression. J. Dermatol. Sci. 73, 117-124.
52. Müller, J., Gorressen, S., Grandoch, M., Feldmann, K., Kretschmer, I., Lehr, S., Ding, Z., Schmitt, J. P., Schrader, J., Garbers, C., Heusch, G., Kelm, M., Scheller, J., and Fischer, J. W. (2014) Interleukin-6-dependent phenotypic modulation of cardiac fibroblasts after acute myocardial infarction. Basic Res. Cardiol. 109, 440.
53. Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., and Weinberg, R. A. (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557-563.
54. Jameson, J. M., Cauvi, G., Sharp, L. L., Witherden, D. A., and Havran, W. L. (2005) Gammadelta T cell-induced hyaluronan production by epithelial cells regulates inflammation. J. Exp. Med. 201, 1269-1279.
55. Scheibner, K. A., Lutz, M. A., Boodoo, S., Fenton, M. J., Powell, J. D., and Horton, M. R. (2006) Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J. Immunol. 177, 1272-1281.
56. Black, K. E., Collins, S. L., Hagan, R. S., Hamblin, M. J., Chan-Li, Y., Hallowell, R. W., Powell, J. D., and Horton, M. R. (2013) Hyaluronan fragments induce IFN via a novel TLR4-TRIF-TBK1-IRF3-dependent pathway. J. Inflamm. 10, 23.
57. Tammi, R. H., Passi, A. G., Rilla, K., Karousou, E., Vigetti, D., Makkonen, K., and Tammi, M. I. (2011) Transcriptional and post-translational regulation of hyaluronan synthesis. FEBS J. 278, 1419-1428.
58. Evanko, S. P., Potter-Perigo, S., Bollyky, P. L., Nepom, G. T., and Wight, T. N. (2012) Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration. Matrix Biol. 31, 90-100.
59. Gooden, M. J., de Bock, G. H., Leffers, N., Daemen, T., and Nijman, H. W. (2011) The prognostic influence of tumour-infiltrating lymphocytes in cancer: A systematic review with meta-analysis. Br. J. Cancer 105, 93-103.
60. Bollyky, P. L., Falk, B. A., Long, S. A., Preisinger, A., Braun, K. R., Wu, R. P., Evanko, S. P., Buckner, J. H., Wight, T. N., and Nepom, G. T. (2009) CD44 costimulation promotes FoxP3 regulatory T cell persistence and function via production of IL-2, IL-10, and TGF. J. Immunol. 183, 2232-2241.
61. Bollyky, P. L., Lord, J. D., Masewicz, S. A., Evanko, S. P., Buckner, J. H., Wight, T. N., and Nepom, G. T. (2007) Cutting edge: high molecular weight hyaluronan promotes the suppressive effects ofCD4-CD25-regulatory T cells. J. Immunol. 179, 744-747.
62. Zhang, Q., Qin, J., Zhong, L., Gong, L., Zhang, B., Zhang, Y., and Gao, W. Q. (2015) CCL5-mediated Th2 immune polarization promotes metastasis in luminal breast cancer. Cancer Res. 75, 4312-4321.
63. Jayasinghe, M. M., Golden, J. M., Nair, P., O'Donnell, C. M., Werner, M. T., and Kurt, R. A. (2008) Tumor-derived CCL5 does not contribute to breast cancer progression. Breast Cancer Res. Treat. 111, 511-521.
64. Serrels, A., Lund, T., Serrels, B., Byron, A., McPherson, R. C., von Kriegsheim, A., Gómez-Cuadrado, L., Canel, M., Muir, M., Ring, J. E., Maniati, E., Sims, A. H., Pachter, J. A., Brunton, V. G., Gilbert, N., Anderton, S. M., Nibbs, R. J., and Frame, M. C. (2015) Nuclear FAK controls chemokine transcription, Tregs, and evasion of anti-tumor immunity. Cell 163, 160-173.
65. Chang, L. Y., Lin, Y. C., Mahalingam, J., Huang, C. T., Chen, T. W., Kang, C. W., Peng, H. M., Chu, Y. Y., Chiang, J. M., Dutta, A., Day, Y. J., Chen, T. C., Yeh, C. T., and Lin, C. Y. (2012) Tumor-derived chemokine CCL5 enhances TGF-mediated killing of CD8(-) T cells in colon cancer by T-regulatory cells. Cancer Res. 72, 1092-1102.
66. Liu, J., Li, F., Ping, Y., Wang, L., Chen, X., Wang, D., Cao, L., Zhao, S., Li, B., Kalinski, P., Thorne, S. H., Zhang, B., and Zhang, Y. (2015) Local production of the chemokines CCL5 and CXCL10 attracts CD8 T lymphocytes into esophageal squamous cell carcinoma. Oncotarget 6, 24978 -24989.
67. Menzies-Gow, A., Ying, S., Sabroe, I., Stubbs, V. L., Soler, D., Williams, T. J., and Kay, A. B. (2002) Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- And late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J. Immunol. 169, 2712-2718.
68. Sallusto, F., Mackay, C. R., and Lanzavecchia, A. (1997) Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277, 2005-2007.
69. Salcedo, R., Young, H. A., Ponce, M. L., Ward, J. M., Kleinman, H. K., Murphy, W. J., and Oppenheim, J. J. (2001) Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3 endothelial cells. J. Immunol. 166, 7571-7578.
70. Kataoka, S., Konishi, Y., Nishio, Y., Fujikawa-Adachi, K., and Tominaga, A. (2004) Antitumor activity of eosinophils activated by IL-5 and eotaxin against hepatocellular carcinoma. DNA Cell Biol. 23, 549-560.
71. Simson, L., Ellyard, J. I., Dent, L. A., Matthaei, K. I., Rothenberg, M. E., Foster, P. S., Smyth, M. J., and Parish, C. R. (2007) Regulation of carcinogenesis by IL-5 and CCL11: A potential role for eosinophils in tumor immune surveillance. J. Immunol. 178, 4222-4229.
72. Mattes, J., Hulett, M., Xie, W., Hogan, S., Rothenberg, M. E., Foster, P., and Parish, C. (2003) Immunotherapy of cytotoxicTcell-resistant tumors byT helper 2 cells: An eotaxin and STAT6-dependent process. J. Exp. Med. 197, 387-393.